KALA
KALA BIO, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.54
−4.53%Next report
Analyst consensus
- Next report date
- Nov 10, 2026
- EPS estimate
- -$6.00
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 19, 2026
- EPS actual
- -$21
- EPS estimate
- -$6.00
- Revenue actual
- —
- Revenue estimate
- $25.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -39.2%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 19, 2026 | -$6.00 | -$21 | Miss -255.33% | — |
| May 15, 2026 | -$8.50 | -$0.14 | Beat 98.35% | — |
| Nov 19, 2025 | -$1.01 | -$1.07 | Miss -5.94% | — |
| Aug 8, 2025 | -$1.82 | -$1.71 | Beat 6.04% | — |
| Mar 31, 2025 | -$2.28 | -$1.74 | Beat 23.68% | $254.0K |
| Mar 29, 2024 | -$3.62 | -$3.18 | Beat 12.15% | $70.0K |
| Nov 13, 2023 | -$2.15 | -$3.41 | Miss -58.60% | — |
| Aug 4, 2023 | -$3.19 | -$4.36 | Miss -36.68% | — |
| Mar 3, 2023 | -$6.56 | -$7.97 | Miss -21.49% | $1.2M |
| Aug 11, 2022 | -$22 | -$19 | Beat 13.64% | $2.1M |
| May 16, 2022 | -$18 | -$23 | Miss -25.00% | $1.4M |
| Nov 15, 2021 | -$23 | -$22 | Beat 4.44% | $3.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 10, 2026